Simplex Trading

Simplex Trading Portfolio holdings

AUM $4.53B
1-Year Est. Return 0.99%
 

Simplex Trading, founded in 2004 and headquartered in Chicago, Illinois, is a technology-driven proprietary trading firm specializing in market-making and liquidity provision, primarily in U.S. equity options and futures options. Leveraging advanced proprietary software and data-driven analysis, the firm optimizes trading strategies and develops innovative solutions to capitalize on financial market opportunities, maintaining a competitive edge through automation and a collaborative team of technologists and traders. With a workforce exceeding 300 and led by CEO Erik Swanson since 2014, Simplex operates with a low-ego, high-intelligence culture, focusing on minimal bureaucracy and rapid execution, while also making strategic venture capital investments in fintech startups. Recognized as a top workplace in Chicago by Built In’s 2025 awards, Simplex continues to evolve, blending cutting-edge technology with a commitment to market efficiency and growth.

This Quarter Est. Return
1 Year Est. Return
+0.99%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.53B
AUM Growth
+$819M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
4,596
New
Increased
Reduced
Closed

Top Buys

1 +$237M
2 +$103M
3 +$93.9M
4
IBIT icon
iShares Bitcoin Trust
IBIT
+$80.5M
5
PDD icon
Pinduoduo
PDD
+$61.3M

Top Sells

1 +$129M
2 +$108M
3 +$89.1M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$79.3M
5
MU icon
Micron Technology
MU
+$64.3M

Sector Composition

1 Technology 34.04%
2 Consumer Discretionary 13.08%
3 Healthcare 10.63%
4 Financials 7.02%
5 Industrials 3.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMDX icon
1026
Transmedics
TMDX
$3.95B
$241K ﹤0.01%
2,151
-13,998
IMVT icon
1027
Immunovant
IMVT
$4B
$240K ﹤0.01%
14,932
+10,126
ZVRA icon
1028
Zevra Therapeutics
ZVRA
$520M
$240K ﹤0.01%
+25,328
EYPT icon
1029
EyePoint Pharmaceuticals
EYPT
$953M
$238K ﹤0.01%
16,741
+14,597
PPL icon
1030
PPL Corp
PPL
$27B
$237K ﹤0.01%
+6,385
DEO icon
1031
Diageo
DEO
$53.4B
$235K ﹤0.01%
2,465
+1,972
PHAT icon
1032
Phathom Pharmaceuticals
PHAT
$1.06B
$234K ﹤0.01%
+19,960
WRB icon
1033
W.R. Berkley
WRB
$29.2B
$234K ﹤0.01%
+3,060
OPK icon
1034
Opko Health
OPK
$983M
$233K ﹤0.01%
+150,566
SRTA
1035
Strata Critical Medical Inc
SRTA
$422M
$232K ﹤0.01%
46,033
-387
TLS icon
1036
Telos
TLS
$460M
$232K ﹤0.01%
+33,920
DOX icon
1037
Amdocs
DOX
$8.38B
$231K ﹤0.01%
+2,821
ILMN icon
1038
Illumina
ILMN
$18.3B
$231K ﹤0.01%
+2,438
LTBR icon
1039
Lightbridge
LTBR
$581M
$231K ﹤0.01%
+10,929
BLCO icon
1040
Bausch + Lomb
BLCO
$5.56B
$230K ﹤0.01%
15,326
-2,753
BZFD icon
1041
BuzzFeed
BZFD
$36.4M
$230K ﹤0.01%
135,354
+36,354
FRHC icon
1042
Freedom Holding
FRHC
$8.41B
$230K ﹤0.01%
1,338
-626
NCNO icon
1043
nCino
NCNO
$2.95B
$230K ﹤0.01%
8,488
-5,009
CMPR icon
1044
Cimpress
CMPR
$1.67B
$229K ﹤0.01%
3,638
-5,591
GSIT icon
1045
GSI Technology
GSIT
$265M
$229K ﹤0.01%
62,339
+42,393
OTIS icon
1046
Otis Worldwide
OTIS
$35.3B
$229K ﹤0.01%
2,509
-642
CRBP icon
1047
Corbus Pharmaceuticals
CRBP
$188M
$227K ﹤0.01%
17,950
+15,131
ELS icon
1048
Equity Lifestyle Properties
ELS
$12B
$227K ﹤0.01%
+3,742
KOD icon
1049
Kodiak Sciences
KOD
$997M
$227K ﹤0.01%
13,878
+9,003
NAGE
1050
Niagen Bioscience
NAGE
$558M
$227K ﹤0.01%
+24,398